News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Expands Succession Planning
07/30/2009

Company introduces dedicated team of business planning experts to help community pharmacists buy and sell independent pharmacies

WASHINGTON, D.C., July 30, 2009 — At its annual Retail Business Conference in Washington, D.C., Cardinal Health today announced that it has expanded its succession planning and acquisition services for independent pharmacies.

Since initially launching these services in October 2008, Cardinal Health’s Transition Strategy and Management team has worked with more than 125 pharmacists interested in buying or selling an independent pharmacy.  Because Cardinal Health serves more than 5,000 independent pharmacies throughout the United States, the company is uniquely positioned to match potential buyers and sellers and to help develop acquisition and exit strategies that take into consideration the specific challenges these owners face.

“Cardinal Health understands that to many independent pharmacists, planning for the future of their businesses is much like planning for the future of their families,” said Jimmy Neil, vice president of Transition Strategy and Management for Cardinal Health. “It’s extremely important – but it can also be a complicated, lengthy and emotional process. Studies show that ownership of more than 60 percent of community pharmacies will change hands within the next 10 years, so we’re committed to making sure that independent pharmacies have all of the information and expertise they need to buy, sell or create a long-term exit strategy for their business.”

Cardinal Health’s Transition Strategy and Management team can help independent pharmacists to determine the best timing to buy or sell a pharmacy, learn how to structure the sales transaction and understand what kind of additional outside counsel they need.

Cardinal Health can also help independent pharmacy buyers to:

  • Determine whether to pursue a start-up or acquisition;
  • Locate and qualify potential sellers;
  • Learn how to get attractive financing and how to negotiate a fair purchase price;
  • Create a long-term business plan, complete with a built-in exit strategy; and
  • Redesign newly purchased pharmacies to create a fresh, more efficient workflow.

Additionally, Cardinal Health can help independent pharmacy sellers to:

  • Locate and qualify potential buyers;
  • Learn how to market their business for sale and how to negotiate a fair sales price; and
  • Determine how to invest the proceeds and what their role will be following the sale.

“Cardinal Health offered me a tremendous amount of personal, hands-on support to guide me through every step of finding and buying the right pharmacy,” said John D. Ortego, PharmD, owner of Parkside Pharmacy in Sacramento, Calif. “They helped me learn about different pharmacy business models, negotiate the lease, understand the financing issues, think through changes I wanted to make to the store’s design and even helped me create a long-term business plan. Cardinal Health treated every detail of my pharmacy buying and building experience like it was their own, and their invaluable guidance and expertise played a key role in helping me realize my dream of pharmacy ownership.”

Cardinal Health’s Transition Strategy and Management services are available to all independent pharmacy owners, pharmacy students and to pharmacists who aren’t currently affiliated with an independent pharmacy but are considering independent pharmacy ownership. 


About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.  With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, MedMined™ electronic infection surveillance service and VIASYS® respiratory care products.  The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide.  Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents.  More information about the company may be found at cardinalhealth.com.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields